Cargando…

The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study

BACKGROUND: The COVID-19 pandemic has raised unprecedented challenges in the management of patients with cancer and has increased the demands for digital health tools that, for example, could facilitate remote monitoring of patients. Based on this, the Gruppo Italiano Malattie Ematologiche dell’Adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Efficace, Fabio, Breccia, Massimo, Fazi, Paola, Cottone, Francesco, Holzner, Bernhard, Vignetti, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2021
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171289/ https://www.ncbi.nlm.nih.gov/pubmed/33890580 http://dx.doi.org/10.2196/25271

Ejemplares similares

Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform
por: Efficace, Fabio, et al.
Publicado: (2022)

COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey
por: Breccia, Massimo, et al.
Publicado: (2020)

Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine
por: Breccia, M., et al.
Publicado: (2022)

Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients
por: Breccia, Massimo, et al.
Publicado: (2017)

How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey
por: Palandri, Francesca, et al.
Publicado: (2020)

Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA
por: Efficace, Fabio, et al.
Publicado: (2023)

Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey
por: Breccia, Massimo, et al.
Publicado: (2023)

P495: UNLOCKING THE POTENTIAL OF SYNTHETIC PATIENTS FOR ACCELERATING CLINICAL TRIALS: RESULTS OF THE FIRST GIMEMA EXPERIENCE
por: Piciocchi, Alfonso, et al.
Publicado: (2023)

A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol
por: Chiaretti, Sabina, et al.
Publicado: (2021)

Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol
por: Messina, Monica, et al.
Publicado: (2022)

ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
por: Buccisano, Francesco, et al.
Publicado: (2022)

The Postpandemic Conference Boom
por: Singh, Shishir
Publicado: (2022)

P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY MULTILEVEL PROPENSITY SCORE WEIGHTING HIGHLIGHTS THE BENEFIT OF THE ADDITION OF VENETOCLAX IN NO LOW-RISK AML TREATED IN GIMEMA TRIALS AND REAL WORLD
por: Piciocchi, Alfonso, et al.
Publicado: (2023)

Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms
por: Saini, Kamal S., et al.
Publicado: (2020)

Forensic medicine in postpandemic time()
por: Grijalba, Marta, et al.
Publicado: (2021)

Telehealth Physical Therapy for Sports Medicine Rehabilitation: What Is Its Role in the Postpandemic Era?
por: Kim, Billy I., et al.
Publicado: (2022)

Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials
por: Ramadan, Safaa M., et al.
Publicado: (2020)

Financial Inclusion Paradigm Shift in the Postpandemic Period. Digital-Divide and Gender Gap
por: Vasile, Valentina, et al.
Publicado: (2021)

Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review
por: Efficace, Fabio, et al.
Publicado: (2022)

Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study
por: Marasco, Vincenzo, et al.
Publicado: (2022)

Adapting to Succeed in Radiology’s Postpandemic Future
por: McGinty, Geraldine B., et al.
Publicado: (2020)

Nursing Workforce Challenges in the Postpandemic World
por: Kurtzman, Ellen T., et al.
Publicado: (2022)

Characteristics, likelihood and challenges of road traffic injuries in China before COVID-19 and in the postpandemic era
por: Yuan, Ping, et al.
Publicado: (2023)

Passive Data Use for Ethical Digital Public Health Surveillance in a Postpandemic World
por: Kilgallon, John L, et al.
Publicado: (2022)

A Digital Mask-Voiceprint System for Postpandemic Surveillance and Tracing Based on the STRONG Strategy
por: Pan, Xiaogao, et al.
Publicado: (2023)

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study
por: Efficace, F, et al.
Publicado: (2012)

American Society of Hematology 2020 Podcast Collection: CML
por: Breccia, Massimo
Publicado: (2021)

American Society of Hematology 2020 Podcast Collection: MPN
por: Breccia, Massimo
Publicado: (2021)

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy
por: Efficace, Fabio, et al.
Publicado: (2021)

Cancer Care Delivery Challenges in India during the COVID-19 Era: Are We Prepared for the Postpandemic Shock?
por: Shankar, Abhishek, et al.
Publicado: (2020)

Effect of wearing medical protective masks on treadmill running performance in the postpandemic era: a randomised trial
por: Wang, I-Lin, et al.
Publicado: (2023)

Ageism in the era of digital platforms
por: Rosales, Andrea, et al.
Publicado: (2020)

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group
por: Rigolin, Gian Matteo, et al.
Publicado: (2021)

Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year follow-up of the GIMEMA CML 0307 study
por: Gugliotta, Gabriele, et al.
Publicado: (2022)

Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network
por: Specchia, Giorgina, et al.
Publicado: (2021)

Global health and human rights for a postpandemic world
por: Khosla, Rajat, et al.
Publicado: (2020)

Transform or Perish: Preparing the Business for a Postpandemic Future
Publicado: (2020)

The perceived effectiveness and hidden inequity of postpandemic fiscal stimuli
por: Zhang, Yaxin, et al.
Publicado: (2022)

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
por: Bassan, Renato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ds0badg61r1gu8gkfijst42hcg